A Full Service Intellectual Property Firm

Safeguarding innovation demands proactive IP counsel known for thought leadership and creative legal strategies. Safeguarding innovation demands Oblon.

Firm News

Oblon Featured in Alexandria News

Oblon has been featured in Alexandria News in regards to three attorneys being elevated to Partners. 

More
Firm News

Justices Urged To Undo Standing Limits On PTAB Appeals

In a petition for a writ of certiorari, JTEKT said it is planning a product that may be at risk of a suit by rival GKN Automotive Ltd. alleging infringement of the patent at issue on a drivetrain for a four-wheel drive vehicle, though no suit has been filed. 

More
Firm News

Oblon Files Petition for Certiorari in PTAB Standing Issue in JTEKT vs. GKN Automotive LTD.

Oblon has filed a petition for certiorari after the United States Court of Appeals for the Federal Circuit declined its petition for panel rehearing and rehearing en banc on behalf of its client, JTEKT Corporation, an engineering and manufacturing company and subsidiary of Toyota.

More

A Voluntary Dismissal without Prejudice does not Yield a Prevailing Party for Purposes of Fee Shifting under the Defend Trade Secrets Act

In its first case construing the Defend Trade Secrets Act, the U.S. Court of Appeals for the Fifth Circuit held that defendants were properly denied attorneys’ fees after the district court granted the plaintiff’s Rule 41(a)(2) motion to dismiss the case without prejudice because the defendants were not “prevailing parties” under the Act, 18 U.S.C.S. § 1836 (b) (3) (D).

More

After SAS, Will Estoppel Also Apply to Grounds not Included in Petitions for Inter Partes Review and Post-Grant Review?

Since the Supreme Court’s decision in SAS Institute Inc. v. Iancu, 138 S. Ct. 1348 (2018), there has been significant discussion on SAS’s expected effect on estoppel for IPRs.  

More

The Federal Circuit Still Doesn’t Get Diagnostic Claims

In Roche Diagnostics the Federal Circuit continued its failure to recognize that diagnostic claims were not patent ineligible because they used a natural law.  Roche involved claims detecting the Mycobacterium tuberculosis strains (MTB) quickly and accurately. 

More

2019 ABA-IPL Annual Meeting and 34th Intellectual Property Law Conference

Oblon is proud to be a gold level Sponsor (Women in IP Luncheon) of the 2019 ABA-IPL Annual Meeting and 34th Intellectual Property Law Conference on April 10-12, 2019 in Arlington, VA.

More

AUTM 2019 Annual Meeting - Austin, TX

Oblon is pleased to be a sponsor of the AUTM 2019 Annual Meeting Feb 10-13 in Austin, TX

More

SEBIO Investor & Partnering Forum 2018

Oblon is proud to be sponsor of the SEBIO Investor & Partnering Forum 2018.

The conference provides an unparalleled opportunity to meet key decision makers in the regional and national life science and medical technology communities.

More

Chambers & Partners USA: America’s Leading Lawyers for Business

Oblon is honored to receive a prestigious Band 1 ranking from Chambers & Partners USA. The publication identified the firm as one of Northern Virginia’s leading firms in the area of intellectual property law.

More

Oblon Named a "Best Law Firm" by U.S. News and World Report

Oblon was named one of the “Best Law Firms” in the United States in 2019 by U.S. News and World Report and Best Lawyers.

More

Oblon Honored in The Legal 500 United States 2018

Oblon has been honored by The Legal 500 as one of America's leading firms in the area of patent: Prosecution (including reexamination and Post-Grant Proceedings).

More
Select an Attorney Select a Service Contact Us